Technology

Formation Bio is building a new kind of pharma company, striving for the impact of a large pharma organization, but the agility and streamlined systems of a tech company. We acquire and in-license high-potential assets and advance them through key value inflection points using proprietary technology. Our AI systems are designed to accelerate and improve decisions across the entire development lifecycle. By integrating interconnected data and AI tools, our platform redefines how assets are sourced, evaluated, and developed—driving faster, more precise, and more efficient progress.

Our Technology Platform

01

Drug Hunting

We’re transforming drug selection with AI that sees around corners, revolutionizing how to identify and acquire breakthrough medicines. Our tools systematically map the therapeutic landscape, surface whitespace, and prioritize the most promising opportunities. We're extending these tools into our AI Drug Hunter system, which autonomously scouts, evaluates, and recommends high-potential assets across therapeutic areas—a continuously learning agent we’re building that will autonomously scout, evaluate, and recommend high-potential assets across therapeutic areas.

  • Therapeutic landscape analysis & ROI modeling Systematically identify unmet needs and forecast the clinical, commercial, and strategic potential of new drug opportunities.

  • Indication mapping, knowledge graphs & AI evaluation Algorithmically match assets to high-value indications, uncover hidden links across drugs, biology, and disease, and prioritize opportunities using agentic AI and LLM-based systems.

  • Real-time intelligence & trend detection Integrate dynamic market signals and external data to maintain a forward-looking view of emerging therapeutic trends and opportunities.

02

R&D Strategy

We’re building a differentiated R&D tech stack that makes drug development faster, smarter, and more strategic. Our AI tools power critical decisions across trial design, regulatory planning, and program strategy—laying the foundation for an AI Drug Developer, a holistic assistant that can shape, simulate, and support every aspect of a program’s development journey.

  • Strategic AI copilots Deliver AI-driven guidance across regulatory planning, protocol drafting, and key cross-functional areas like CMC, Regulatory, and Commercial.

  • Predictive planning & scenario modeling Forecast enrollment, budgets, and timelines while simulating development paths to optimize for success probability, speed, and ROI.

  • AI-generated trial design Use structured data and real-world benchmarks to create more efficient, evidence-based trial protocols.

03

Clinical Trials

We’re building AI automation for trials that run faster and smarter. Our AI systems aim to reduce manual work, accelerate timelines, and improve trial quality. Our technology is designed to ultimately build an Automated Clinical Trial—a future where trials are intelligently orchestrated, monitored in real time, and largely self-managed.

  • Automated study startup & documentation Accelerate site activation with AI-driven workflows that generate, populate, and maintain key trial documents—reducing cycle times and manual effort across study setup.

  • AI-optimized recruitment strategies Use AI to model recruitment pathways, generate targeted outreach content, and optimize channel selection to improve enrollment speed and success.

  • Intelligent validation & monitoring Streamline database build with smarter validation protocols and enable real-time, risk-based site monitoring through automated data review and anomaly detection.

Learn more about how we bring together tech and drug development expertise.

© Formation Bio 2025
Site Credit